Ageing, smoking and oxidative stress

Donohue, J. F.
June 2006
Thorax;Jun2006, Vol. 61 Issue 6, p461
Academic Journal
The article discusses that chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death worldwide. Continued exposure to tobacco promotes a more rapid decline in lung function, and if exposure is stopped, the disease may still progress to aging and persistent inflammation. There is a considerable evidence that oxidative in cigarette smoke cause lung injury, depletion of other antioxidants, and direct damage to lipid, nucleic acids, and proteins.


Related Articles

  • Convergent Sets of Data from In Vivo and In Vitro Methods Point to an Active Role of Hsp60 in Chronic Obstructive Pulmonary Disease Pathogenesis. Cappello, Francesco; Caramori, Gaetano; Campanella, Claudia; Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; Rocca, Giampiero La; Anzalone, Rita; Bucchieri, Fabio; D'Anna, Silvestro Ennio; Ricciardolo, Fabio L. M.; Brun, Paola; Balbi, Bruno; Carone, Mauro; Zummo, Giovanni; de Macario, Everly Conway; Macario, Alberto J. L.; Di Stefano, Antonino // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: It is increasingly clear that some heat shock proteins (Hsps) play a role in inflammation. Here, we report results showing participation of Hsp60 in the pathogenesis of chronic obstructive pulmonary diseases (COPD), as indicated by data from both in vivo and in vitro analyses....

  • Does vitamin E supplementation help in COPD? Jindal, S. K. // Indian Journal of Medical Research;Dec2008, Vol. 128 Issue 6, p686 

    The author focuses on whether vitamin E supplementation helps in the prevention and management of chronic obstructive pulmonary disease (COPD). The author provides information on the results of a study from India wherein the authors report an augmentation of antioxidant defenses but no clinical...

  • Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease. Hackett, Tillie L.; Scarci, Marco; Lu Zheng; Wan Tan; Treasure, Tom; Warner, Jane A. // Respiratory Research;2010, Vol. 11, p180 

    Background: There is accumulating evidence that oxidative stress plays an important role in the pathophysiology of chronic obstructive pulmonary disease (COPD). One current hypothesis is that the increased oxidant burden in these patients is not adequately counterbalanced by the lung antioxidant...

  • Smoking status and tumour necrosis factor-alpha mediated systemic inflammation in COPD patients. Tanni, Suzana E.; Pelegrino, Nilva R. G.; Angeleli, Aparecida Y. O.; Correa, Camila; Godoy, Irma // Journal of Inflammation;2010, Vol. 7, p29 

    Background: Smoking cause airway and systemic inflammation and COPD patients present low grade inflammation in peripheral blood. However, data on the influence of smoking itself on systemic inflammation in COPD patients are scarce. This study investigated the association between inflammation,...

  • Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. Arunachalam, Gnanapragasam; Sundar, Isaac K.; Jae-woong Hwang; Hongwei Yao; Rahman, Irfan // Journal of Inflammation;2010, Vol. 7, p34 

    Background: Chronic obstructive pulmonary disease is associated with numerous vascular effects including endothelial dysfunction, arterial stiffness and atherogenesis. It is also known that a decline in lung function is associated with increased cardiovascular comorbidity in smokers. The...

  • Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers. Karimi, Reza; Tornling, Göran; Forsslund, Helena; Mikko, Mikael; Wheelock, Åsa M.; Nyrén, Sven; Sköld, Carl Magnus // Respiratory Research;2014, Vol. 15 Issue 2, p1 

    Background: Smokers have increased cell concentration in the lower respiratory tract indicating a chronic inflammatory state, which in some individuals may lead to development of chronic obstructive pulmonary disease (COPD). Computer tomography (CT) imaging provides means of quantifying...

  • Small airway epithelial-C/EBPβ is increased in patients with advanced COPD. Mori, Michiko; Bjermer, Leif; Erjefält, Jonas S.; Stampfli, Martin R.; Roos, Abraham B. // Respiratory Research;10/29/2015, Vol. 16 Issue 1, p1 

    The expression of CCAAT/enhancer-binding protein (C/EBP)β in the small airway epithelium of COPD is unknown. C/EBPβ was assessed in peripheral lung tissue of non-smoking/smoking controls and patients with GOLD I-IV COPD by quantitative immunohistochemistry. The expression of C/EBPβ was...

  • Profiling the Proteome of Exhaled Breath Condensate in Healthy Smokers and COPD Patients by LC-MS/MS. Fumagalli, Marco; Ferrari, Fabio; Luisetti, Maurizio; Stolk, Jan; Hiemstra, Pieter S.; Capuano, Daniela; Viglio, Simona; Fregonese, Laura; Cerveri, Isa; Corana, Federica; Tinelli, Carmine; Iadarola, Paolo // International Journal of Molecular Sciences;Nov2012, Vol. 13 Issue 11, p13894 

    Three pools of exhaled breath condensate (EBC) from non-smokers plus healthy smokers (NS + HS, n = 45); chronic obstructive pulmonary disease (COPD) without emphysema (COPD, n = 15) and subjects with pulmonary emphysema associated with α1-antitrypsin deficiency (AATD, n = 23) were used for an...

  • Variability in the precursor proteins of collagen I and III in different stages of COPD. Harju, Terttu; Kinnula, Vuokko L.; Pääkkö, Paavo; Salmenkivi, Kaisa; Risteli, Juha; Kaarteenaho, Riitta // Respiratory Research;2010, Vol. 11, p165 

    Background: Levels of precursor proteins of collagen I and III are increased in fibrotic pulmonary diseases. This study determined whether the expression of precursors of type I and III collagen proteins would be increased in small and large airways of COPD patients in various stages of the...


Read the Article


Sign out of this library

Other Topics